Navigation Links
Rcadia Medical Imaging Awarded Four U.S. Patents Covering Technology for Automated Analysis of Coronary CT Angiography
Date:6/28/2011

NEWTON, Mass., June 28, 2011 /PRNewswire/ -- Rcadia Medical Imaging today announced that the company has been granted four patents by the U.S. Patent and Trademark Office covering technology for its COR Analyzer® System.  The COR Analyzer performs fully automatic analysis of Coronary CT Angiography (cCTA) studies to accelerate emergency department triage of suspected coronary artery disease (CAD) patients and optimize cardiology and radiology department workflow. The System is marketed in the U.S. and distributed through an agreement with Siemens Healthcare.

"The COR Analyzer is a powerful decision support tool which has shown great potential in clinical trials and routine use to reduce unnecessary admissions and shorten time to treatment," said Shai Levanon, President and CEO of Rcadia. "The patents strengthen the intellectual property position around this innovative system."  He noted that the COR Analyzer is the first of a new category of software applications to broadly enable the use of advanced imaging technologies in emergency medicine to improve care and reduce costs.

The four patents broadly cover methods and algorithms for automated analysis of coronary CT angiography studies and detection of pathologies in coronary arteries. The patents also cover methods for results visualization and automatic assessment of study quality. In addition, the methods are extended to cover the automatic interpretation of triple rule out studies.

Triage of suspected CAD patients represents a major clinical and healthcare economic challenge in the U.S.  An estimated six million patients enter the ED in the U.S. each year with chest pain. Because current diagnostic techniques are often equivocal, an estimated two million, primarily low risk patients, are admitted to the hospital for further testing at an annual cost of $10-$13 billion. In an estimated 85 percent of these patients, an acute coronary event is subsequently ruled out.

About Rcadia Medical Imaging

Rcadia Medical Imaging develops and markets automated image processing software products for blood vessel analysis in patients with suspected cardiovascular disease. The company's first FDA-cleared product, the COR Analyzer® System, provides fully automated, real-time analysis of Coronary CT Angiography to enable the practical application of cCTA in detecting significant coronary artery disease. The COR Analyzer improves the utility of Coronary CTA studies in the emergency department to triage chest pain patients and optimizes work flow in cardiology and radiology departments. Learn more at www.rcadia.com.


'/>"/>
SOURCE Rcadia Medical Imaging Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rcadias COR Analyzer Family of Products Receives Second FDA Clearance
2. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
3. Rcadia Medical Imaging Wins 2009 AuntMinnie.com Best New Radiology Vendor Award
4. Arcadia Resources Announces Webcast of Its Fiscal 2010 Second Quarter Conference Call
5. Arcadia Resources to Present at Lazard Healthcare Conference in New York
6. Arcadia Resources Names Stephen Goldsmith to Board of Directors
7. Rcadia Medical Imaging’s COR Analyzer(R) System Receives CE Mark
8. Marcadia and Lilly Sign Development, License Agreement for Novel Glucagon Program in Severe Hypoglycemia
9. Rcadia Announces Five COR Analyzer® Studies to be Presented at SCCT Annual Scientific Meeting
10. Arcadian Healths Chief Information Officer to Address Role of CIOs from a Healthcare Perspective at the CIO Executive Leadership Roundtable in Santa Monica
11. Arcadia Resources Announces Improved Fiscal 2011 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/22/2017)... ROCKVILLE, Md. , Sept. 22, 2017  As ... by Republican Senators Bill Cassidy (R-LA) and ... Kalorama Information notes that the medical device industry is ... the medical device tax, the 2.3% excise tax on ... Act.  But they also want covered patients, increased visits ...
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
Breaking Medicine Technology:
(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
Breaking Medicine News(10 mins):